For more information, visit: www.miltenyibiotec.com/US-en/... Natural Killer (NK) cells are a promising tool in the fight against cancer. Engineering them with chimeric antigen receptors (CARs) further bolsters their specific anti-tumor activity.
For decades, Miltenyi Biotec has been a trusted partner for cell and gene therapy solutions. During this workshop, we will showcase our commitment to developing products that advance your research and give you scalable and reproducible results.
Join us to explore how to isolate functional NK cells directly from blood products, boost your cell engineering, easily activate and expand your NK cells and streamline your IPC and QC with our latest flow analysis solutions.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.